Obexelimab, Zenas Biopharma’s experimental, self-administered injectable therapy, reduced the risk of disease flares in adults with immunoglobulin G4-related…
Articles by Steve Bryson PhD
The risk of developing cancer is more than four times higher in people with immunoglobulin G4-related disease (IgG4-RD) compared…
Nearly one in 10 people with immunoglobulin G4-related disease (IgG4-RD) also have at least one co-existing autoimmune disease, according…
People with the inflammatory condition IgG4-related disease (IgG4-RD) face a more severe form of illness when their pancreas is…
An advisory committee of the European Medicines Agency, or EMA — which evaluations medications for drug approval in the European…